concept

NEURODEGENERATIVE DISEASE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEURODEGENERATIVE DISEASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

334Connections

0Hypotheses

21Analyses

43Outgoing

50Incoming

No summary available yet. View on Wiki →

💡 Concept Info

Name	NEURODEGENERATIVE DISEASE
Key Genes/Proteins	SIRT1, Proteins
Related Diseases	Cognitive Decline, Type 2 Diabetes
Related Pathways	Telomere

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

→

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

→

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

→

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

→

Pathway Diagram

graph TD
    NEURODEGENERATIVE_DISEASE["<b>NEURODEGENERATIVE DISEASE</b>"]
    Protein_Misfolding["Protein Misfolding"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE
    Intercellular_Protein_Transmis["Intercellular Protein Transmission"] -->|"involved_in"| NEURODEGENERATIVE_DISEASE
    Microglial_Senescence["Microglial Senescence"] -->|"involved_in"| NEURODEGENERATIVE_DISEASE
    Prion_like_Protein_Aggregates["Prion-like Protein Aggregates"] -->|"causes"| NEURODEGENERATIVE_DISEASE
    Genomic_Instability["Genomic Instability"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE
    Telomere_Attrition["Telomere Attrition"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE
    Epigenetic_Alterations["Epigenetic Alterations"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE
    Loss_Of_Proteostasis["Loss Of Proteostasis"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE
    Mitochondrial_Dysfunction["Mitochondrial Dysfunction"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE
    Cellular_Senescence["Cellular Senescence"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE
    Deregulated_Nutrient_Sensing["Deregulated Nutrient Sensing"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE
    Stem_Cell_Exhaustion["Stem Cell Exhaustion"] -->|"contributes to"| NEURODEGENERATIVE_DISEASE

Outgoing (44)

Target	Relation	Type	Str
SYNUCLEIN	interacts_with	concept	0.50
Proteins	interacts_with	protein	0.50
AMYLOID-β	interacts_with	concept	0.50
α-SYNUCLEIN	interacts_with	concept	0.50
Proteins	activates	protein	0.50
CENTRAL NERVOUS SYSTEM	associated_with	concept	0.50
Telomere	interacts_with	pathway	0.50
Proteostasis	interacts_with	process	0.50
Cellular Senescence	interacts_with	cell_type	0.50
Cellular Senescence	activates	cell_type	0.50
SYNUCLEIN	regulates	concept	0.50
Cognitive Decline	associated_with	disease	0.50
NUCLEUS	associated_with	concept	0.50
Type 2 Diabetes	activates	disease	0.50
INSULIN	activates	concept	0.50
Microbiota	regulates	process	0.50
Gut Microbiota	regulates	process	0.50
Microbiota	interacts_with	process	0.50
Dysbiosis	interacts_with	disease	0.50
Gut Microbiota	interacts_with	process	0.50
Microbiota	protects_against	process	0.50
SYNUCLEIN	associated_with	concept	0.50
α-SYNUCLEIN	associated_with	concept	0.50
Cognitive Impairment	inhibits	phenotype	0.50
INSULIN	associated_with	concept	0.50
Proteins	regulates	protein	0.50
Retinopathy	associated_with	disease	0.50
TREM2 RISK VARIANTS	associated_with	concept	0.50
IPSC	associated_with	concept	0.50
Proteins	associated_with	protein	0.50
STRESS GRANULES	associated_with	concept	0.50
Microbiota	associated_with	process	0.50
Gut Microbiota	associated_with	process	0.50
NEUROFIBRILLARY TANGLES	associated_with	concept	0.50
CARDIOVASCULAR DISEASE	interacts_with	concept	0.50
STAU1	expressed_in	concept	0.50
DOPAMINE	associated_with	concept	0.50
AMYLOID-β	associated_with	concept	0.50
TNF SIGNALING	inhibits	concept	0.50
AMYLOID-β	regulates	concept	0.50
NEUROFIBRILLARY TANGLES	inhibits	concept	0.50
SELECTIVE AUTOPHAGY	interacts_with	concept	0.50
DOPAMINERGIC NEURONS	associated_with	concept	0.50

Incoming (290)

Source	Relation	Type	Str
SIRT1	protects_against	protein	0.88
PPAR	protects_against	protein	0.50
disease	protects_against	disease	0.50
PPAR-Γ	protects_against	concept	0.50
HSP70	associated_with	protein	0.50
cancer	associated_with	disease	0.50
disease	associated_with	disease	0.50
amyotrophic lateral sclerosis	causes	gene	0.50
disease	causes	disease	0.50
aging	associated_with	phenotype	0.50
ALZHEIMER	interacts_with	gene	0.50
PARKINSON	interacts_with	gene	0.50
amyotrophic lateral sclerosis	interacts_with	gene	0.50
AMYLOID	interacts_with	gene	0.50
Neurodegenerative Diseases	interacts_with	disease	0.50
Alzheimer Disease	interacts_with	disease	0.50
disease	interacts_with	disease	0.50
Neurodegenerative Diseases	activates	disease	0.50
disease	activates	disease	0.50
GLAUCOMA	regulates	gene	0.50
Neuropathy	regulates	disease	0.50
disease	regulates	disease	0.50
PARKINSON	associated_with	gene	0.50
Parkinson's Disease	associated_with	disease	0.50
PARKINSON'S	associated_with	concept	0.50
Neuron	causes	cell_type	0.50
MOTOR NEURONS	causes	concept	0.50
NEURONS	causes	concept	0.50
UNC13A	activates	gene	0.50
Tdp-43	activates	pathway	0.50
DEMENTIA	activates	gene	0.50
amyotrophic lateral sclerosis	activates	gene	0.50
FRONTOTEMPORAL DEMENTIA	activates	disease	0.50
SYNAPSE	activates	concept	0.50
FRONTOTEMPORAL	activates	concept	0.50
ALZHEIMER	associated_with	gene	0.50
DEMENTIA	associated_with	gene	0.50
amyotrophic lateral sclerosis	associated_with	gene	0.50
Alzheimer'S Disease	associated_with	disease	0.50
Neurodegenerative Diseases	associated_with	disease	0.50
ALZHEIMER'S	associated_with	concept	0.50
FRONTOTEMPORAL	associated_with	concept	0.50
Neuron	associated_with	cell_type	0.50
NEURONS	associated_with	concept	0.50
Alzheimer Disease	associated_with	disease	0.50
Stem Cell	interacts_with	cell_type	0.50
mitophagy	activates	pathway	0.50
NEURONS	activates	concept	0.50
microglia	interacts_with	cell_type	0.50
Neurodegeneration	associated_with	disease	0.50

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (21)

Scientific analyses that reference this entity

What are the precise temporal dynamics of astrocyte ketone production decline du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.645

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

neurodegeneration | 2026-04-15 | 0 hypotheses

Why does autophagy inhibition improve neuronal survival when autophagy is typica

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.557

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.596

What molecular mechanisms enable functional recovery and muscle re-innervation a

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.658

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

NEURODEGENERATIVE DISEASE

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Pathway Diagram

Outgoing (44)

Incoming (290)

Targeting Hypotheses (0)

Mentioning Analyses (21)

What are the precise temporal dynamics of astrocyte ketone production decline du

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

Why does autophagy inhibition improve neuronal survival when autophagy is typica

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

What molecular mechanisms enable functional recovery and muscle re-innervation a

Do transferred mitochondria from diseased astrocytes carry pathological damage t

What determines the selectivity and efficiency of intercellular transmission pat

How do host cell factors influence the conformation and propagation properties o

What molecular mechanisms determine the conformational diversity and strain-like

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

What molecular mechanisms drive microglial senescence and the transition to dyst

Senescent cell clearance as neurodegeneration therapy

CRISPR-based therapeutic approaches for neurodegenerative diseases

CRISPR-based therapeutic approaches for neurodegenerative diseases

Metabolic reprogramming in neurodegenerative disease

Metabolic reprogramming in neurodegenerative disease

Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi

Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi

Protein aggregation cross-seeding across neurodegenerative diseases

Autophagy-lysosome pathway convergence across neurodegenerative diseases

Protein aggregation cross-seeding across neurodegenerative diseases

Related Papers (0)

NEURODEGENERATIVE DISEASE

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

primary-progressive-aphasia

CBS/PSP Supplements Guide

Atypical Parkinsonism

Parthanatos in Neurodegeneration

CBS/PSP Rehabilitation Master Guide

calcium-dysregulation-comparison

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alpha-Synuclein Pathology

PD Combination Therapy Matrix

Alzheimer's Disease Mechanism Index

Pathway Diagram

Outgoing (44)

Incoming (290)

Targeting Hypotheses (0)

Mentioning Analyses (21)

What are the precise temporal dynamics of astrocyte ketone production decline du

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

Why does autophagy inhibition improve neuronal survival when autophagy is typica

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

What molecular mechanisms enable functional recovery and muscle re-innervation a

Do transferred mitochondria from diseased astrocytes carry pathological damage t

What determines the selectivity and efficiency of intercellular transmission pat

How do host cell factors influence the conformation and propagation properties o

What molecular mechanisms determine the conformational diversity and strain-like

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

What molecular mechanisms drive microglial senescence and the transition to dyst

Senescent cell clearance as neurodegeneration therapy

CRISPR-based therapeutic approaches for neurodegenerative diseases

CRISPR-based therapeutic approaches for neurodegenerative diseases

Metabolic reprogramming in neurodegenerative disease

Metabolic reprogramming in neurodegenerative disease

Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi

Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi

Protein aggregation cross-seeding across neurodegenerative diseases

Autophagy-lysosome pathway convergence across neurodegenerative diseases

Protein aggregation cross-seeding across neurodegenerative diseases

Related Papers (0)